Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates

NCT03053076 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Safety Issues
Effect of Drugs
Neonatal Death

Interventions

OTHER: Autologous Umbilical Cord Blood Mononuclear Cells Therapy
DRUG: 0.9% Sodium Chloride

Sponsor

Guangdong Women and Children Hospital